Charles Schwab’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26
| Closed | -$18.3K | – | 3573 |
|
|
2023
Q3 | $18.3K | Buy |
26
+16
| +160% | +$11.3K | ﹤0.01% | 3518 |
|
|
2023
Q2 | $46.8K | Hold |
10
| – | – | ﹤0.01% | 3427 |
|
|
2023
Q1 | $27.1K | Hold |
10
| – | – | ﹤0.01% | 3464 |
|
|
2022
Q4 | $26.6K | Hold |
10
| – | – | ﹤0.01% | 3469 |
|
|
2022
Q3 | $41K | Hold |
10
| – | – | ﹤0.01% | 3377 |
|
|
2022
Q2 | $27K | Sell |
10
-59
| -86% | -$159K | ﹤0.01% | 3496 |
|
|
2022
Q1 | $222K | Buy |
69
+5
| +8% | +$16.1K | ﹤0.01% | 3287 |
|
|
2021
Q4 | $401K | Hold |
64
| – | – | ﹤0.01% | 3220 |
|
|
2021
Q3 | $593K | Buy |
64
+12
| +23% | +$111K | ﹤0.01% | 3086 |
|
|
2021
Q2 | $528K | Buy |
52
+46
| +767% | +$467K | ﹤0.01% | 3155 |
|
|
2021
Q1 | $123K | Buy |
+6
| New | +$123K | ﹤0.01% | 3365 |
|